UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status

Clinical and applied thrombosis/hemostasis, 2019-01, Vol.25, p.1076029618823287-1076029618823287

2019

Volltextzugriff (PDF)

Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA

Drugs in Context, 2019, Vol.8, p.212568-9

2019

Volltextzugriff (PDF)

A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-05, Vol.17 (3), p.494-499

2011

Volltextzugriff (PDF)

Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States

PharmacoEconomics, 2019-05, Vol.37 (5), p.701-714

2019

Volltextzugriff (PDF)

Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US

Journal of medical economics, 2019-11, Vol.22 (11), p.1119-1125

2019

Volltextzugriff (PDF)

Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors

Journal of medical economics, 2017-12, Vol.20 (12), p.1217-1223

2017

Volltextzugriff (PDF)

Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis

Advances in therapy, 2019, Vol.36 (1), p.59-71

2019

Volltextzugriff (PDF)

Effectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients: a systematic literature review and network meta-analysis

Journal of medical economics, 2019-10, Vol.22 (10), p.1063-1072

2019

Volltextzugriff (PDF)

134: REHOSPITALIZATIONS FOR VENOUS THROMBOEMBOLISM AND ASSOCIATED COSTS AMONG PATIENTS WITH HEART FAILURE

Critical care medicine, 2019-01, Vol.47 (1), p.50-50

2019

Volltextzugriff (PDF)

Abstract TP284: The Risk of Venous Thromboembolism Among Patients Hospitalized for Acute Ischemic Stroke in the US

Stroke (1970), 2018-01, Vol.49 (Suppl_1)

2018

Volltextzugriff (PDF)

210: THE RISK OF VENOUS THROMBOEMBOLISM AMONG PATIENTS HOSPITALIZED FOR ACUTE ISCHEMIC STROKE IN THE US

Critical care medicine, 2018-01, Vol.46 (1 Suppl 1), p.87-87

2018

Volltextzugriff (PDF)

214: PROPHYLACTIC VENOUS THROMBOEMBOLISM TREATMENT IN PATIENTS HOSPITALIZED FOR ACUTE INFECTIOUS DISEASE

Critical care medicine, 2018-01, Vol.46 (1 Suppl 1), p.89-89

2018

Volltextzugriff (PDF)

Did Patients with Renal Disease Receive Sufficient Prophylaxis for Venous Thromboembolism in the Real-World Settings?: A Study Among Hospitalized Acutely Medically Ill Patients

Blood, 2017-12, Vol.130, p.3416-3416

2017

Volltextzugriff (PDF)

The Frequency of Venous Thromboembolism (VTE) Prophylaxis Among Patients Hospitalized for Cancer in the US

Blood, 2017-12, Vol.130, p.4734-4734

2017

Volltextzugriff (PDF)

Unmet Needs and Challenges in Clinical Research of Intracerebral Hemorrhage

Stroke (1970), 2018-05, Vol.49 (5), p.1299-1307

2018

Volltextzugriff (PDF)

Basic and Translational Research in Intracerebral Hemorrhage: Limitations, Priorities, and Recommendations

Stroke (1970), 2018-05, Vol.49 (5), p.1308-1314

2018

Volltextzugriff (PDF)

59: ANDEXANET ALFA REVERSES ANTICOAGULATION IN FACTOR XA-ASSOCIATED MAJOR BLEEDING IN ANNEXA-4 STUDY

Critical care medicine, 2019-01, Vol.47 (1), p.30-30

2019

Volltextzugriff (PDF)

Abstract WP385: Burden of Rehospitalizations for Venous Thromboembolism Among Patients With Ischemic Stroke

Stroke (1970), 2019-02, Vol.50 (Suppl_1)

2019

Volltextzugriff (PDF)

Burden of Hospital Readmissions for Venous Thromboembolism Among Patients with Cancer

Blood, 2018-11, Vol.132 (Supplement 1), p.365-365

2018

Volltextzugriff (PDF)

DOES AGE MATTER? EVALUATION OF PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM IN THE REAL-WORLD SETTINGS AMONG HOSPITALIZED ACUTELY MEDICALLY ILL PATIENTS OF DIFFERENT AGE GROUPS

Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A2108-A2108

2018

Volltextzugriff (PDF)

PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM IN THE CONTINUUM OF CARE AMONG PATIENTS WITH ACUTE HEART FAILURE IN THE UNITED STATES

Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A1956-A1956

2018

Volltextzugriff (PDF)

Abstract 135: Extended Thromboprophylaxis With Betrixaban is Cost-effective in Acutely Ill Medical Patients

Circulation Cardiovascular quality and outcomes, 2018-04, Vol.11 (suppl_1)

2018

Volltextzugriff (PDF)

617: MANAGEMENT STRATEGIES OF PATIENTS RECEIVING FXA INHIBITORS OR LMWH ADMITTED FOR ICH

Critical care medicine, 2016-12, Vol.44 (12 Suppl 1), p.230-230

2016

Volltextzugriff (PDF)

A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B: ALLERGIC REACTIONS TO FACTOR IX FOR HAEMOPHILIA B

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-05, Vol.17 (3), p.494-499

2011

Volltextzugriff (PDF)

Treatment Patterns and Outcomes of Patients Receiving Direct Oral Anticoagulants or Low Molecular Weight Heparin who Experienced Life-threatening Intracranial Hemorrhage (P5.053)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(7)
Aged
(5)
Venous Thromboembolism
(5)
Female
(4)
General & Internal Medicine
(4)
Health Care Sciences & Services
(4)
Male
(4)
Medicine, General & Internal
(4)
Middle Aged
(4)
Venous Thromboembolism - Prevention & Control
(4)
Adult
(3)
Cardiovascular System & Cardiology
(3)
Hospitalized Patients
(3)
Peripheral Vascular Disease
(3)
Retrospective Studies
(3)
Risk Factors
(3)
Acute Disease
(2)
Acute Illness
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status

Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA

A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B

Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States

Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US

Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors

Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis

Effectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients: a systematic literature review and network meta-analysis

134: REHOSPITALIZATIONS FOR VENOUS THROMBOEMBOLISM AND ASSOCIATED COSTS AMONG PATIENTS WITH HEART FAILURE

Abstract TP284: The Risk of Venous Thromboembolism Among Patients Hospitalized for Acute Ischemic Stroke in the US

210: THE RISK OF VENOUS THROMBOEMBOLISM AMONG PATIENTS HOSPITALIZED FOR ACUTE ISCHEMIC STROKE IN THE US

214: PROPHYLACTIC VENOUS THROMBOEMBOLISM TREATMENT IN PATIENTS HOSPITALIZED FOR ACUTE INFECTIOUS DISEASE

Did Patients with Renal Disease Receive Sufficient Prophylaxis for Venous Thromboembolism in the Real-World Settings?: A Study Among Hospitalized Acutely Medically Ill Patients

The Frequency of Venous Thromboembolism (VTE) Prophylaxis Among Patients Hospitalized for Cancer in the US

Unmet Needs and Challenges in Clinical Research of Intracerebral Hemorrhage

Basic and Translational Research in Intracerebral Hemorrhage: Limitations, Priorities, and Recommendations

59: ANDEXANET ALFA REVERSES ANTICOAGULATION IN FACTOR XA-ASSOCIATED MAJOR BLEEDING IN ANNEXA-4 STUDY

Abstract WP385: Burden of Rehospitalizations for Venous Thromboembolism Among Patients With Ischemic Stroke

Burden of Hospital Readmissions for Venous Thromboembolism Among Patients with Cancer

DOES AGE MATTER? EVALUATION OF PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM IN THE REAL-WORLD SETTINGS AMONG HOSPITALIZED ACUTELY MEDICALLY ILL PATIENTS OF DIFFERENT AGE GROUPS

PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM IN THE CONTINUUM OF CARE AMONG PATIENTS WITH ACUTE HEART FAILURE IN THE UNITED STATES

Abstract 135: Extended Thromboprophylaxis With Betrixaban is Cost-effective in Acutely Ill Medical Patients

617: MANAGEMENT STRATEGIES OF PATIENTS RECEIVING FXA INHIBITORS OR LMWH ADMITTED FOR ICH

A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B: ALLERGIC REACTIONS TO FACTOR IX FOR HAEMOPHILIA B

Treatment Patterns and Outcomes of Patients Receiving Direct Oral Anticoagulants or Low Molecular Weight Heparin who Experienced Life-threatening Intracranial Hemorrhage (P5.053)

Suchergebnisse filtern